Scott Morrison
Net worth: 1 M $ as of 31/05/2026
Net worth: 1 M $ as of 31/05/2026
Scott William Morrison is currently an Independent Director at Zai Lab Ltd. since 2021, IDEAYA Biosciences, Inc. since 2018, Tarsus Pharmaceuticals, Inc. since 2022, and Vera Therapeutics, Inc. since 2020.
Former positions include Independent Director at Global Blood Therapeutics, Inc. from 2015 to 2022, Independent Director at Astellas Gene Therapies, Inc. from 2015 to 2020, Independent Director at ESCAPE Bio, Inc. from 2020 to 2022, Independent Director at Corvus Pharmaceuticals, Inc. from 2015 to 2026, Partner at Ernst & Young LLP from 1996 to 2015, and Director roles at Biotechnology Innovation Organization, Symic Bio, Inc., The Bay Area Bioscience Association, The Biotechnology Institute (also Treasurer), The Life Sciences Foundation, and California Life Sciences Association.
Education includes undergraduate studies at Haas School of Business.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 31/03/2026 | 10,700 ( 0.02% ) | 635 580 $ | 31/05/2026 | |
ZAI LAB LTD. 0.03% | 10/04/2026 | 3,45,330 ( 0.03% ) | 612 899 $ | 31/05/2026 |
| 31/03/2026 | 0 ( -.--% ) | - $ | 31/05/2026 | |
| 12/06/2025 | 0 ( -.--% ) | - $ | 31/05/2026 | |
| 21/05/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Companies | Position | Start |
|---|---|---|
| IDEAYA BIOSCIENCES, INC. | Director/Board Member | 01/07/2018 |
| VERA THERAPEUTICS, INC. | Director/Board Member | 01/04/2020 |
| ZAI LAB LIMITED | Director/Board Member | 13/10/2021 |
| TARSUS PHARMACEUTICALS, INC. | Director/Board Member | 06/10/2022 |
| Companies | Position | End |
|---|---|---|
| CORVUS PHARMACEUTICALS, INC. | Director/Board Member | 23/04/2026 |
ESCAPE Bio, Inc.
ESCAPE Bio, Inc. BiotechnologyHealth Technology Develops small molecule therapeutics against genetic targets for neurodegenerative disease | Director/Board Member | 01/11/2022 |
| GLOBAL BLOOD THERAPEUTICS, INC. | Director/Board Member | 04/10/2022 |
| AUDENTES THERAPEUTICS, INC. | Director/Board Member | 15/01/2020 |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Corporate Officer/Principal | 01/12/2015 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 16 |
|---|---|
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Commercial Services |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Symic Bio, Inc.
Symic Bio, Inc. BiotechnologyHealth Technology Develops new category of therapeutics | Health Technology |
Corvus Pharmaceuticals, Inc.
Corvus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides anticancer immuno-oncology drugs | Health Technology |
The Bay Area Bioscience Association
The Bay Area Bioscience Association BiotechnologyHealth Technology Provides biomedical communities services | Health Technology |
The Biotechnology Institute
The Biotechnology Institute Miscellaneous Commercial ServicesCommercial Services Focuses on biotechnological research | Commercial Services |
Haas School of Business
Haas School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Global Blood Therapeutics, Inc.
Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which provides treatment and care of sickle cell disease for inherited blood disorder | Health Technology |
Astellas Gene Therapies, Inc.
Astellas Gene Therapies, Inc. BiotechnologyHealth Technology Develops and commercializes gene therapy products for patients with serious rare diseases | Health Technology |
Zai Lab Ltd.
Zai Lab Ltd. BiotechnologyHealth Technology Develops medicine for cancer, autoimmune and infectious diseases | Health Technology |
The Life Sciences Foundation
The Life Sciences Foundation Miscellaneous Commercial ServicesCommercial Services Engages in education and biotechnology information dissemination | Commercial Services |
IDEAYA Biosciences, Inc.
IDEAYA Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as oncology-focused precision medicine company which develops and sells cancer therapeutics | Health Technology |
ESCAPE Bio, Inc.
ESCAPE Bio, Inc. BiotechnologyHealth Technology Develops small molecule therapeutics against genetic targets for neurodegenerative disease | Health Technology |
California Life Sciences Association
California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services Acts as a trade association which represents the life sciences industry of California | Commercial Services |
Tarsus Pharmaceuticals, Inc.
Tarsus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops and commercializes therapeutic drugs for blepharitis | Health Technology |
Vera Therapeutics, Inc.
Vera Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company, which focuses on development and treatments for immunological & inflammatory diseases | Health Technology |
Select your edition
All financial news and data tailored to specific country editions